SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025437
Filing Date
2020-09-16
Accepted
2020-09-16 20:44:17
Documents
1
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2949
  Complete submission text file 0000899243-20-025437.txt   4500
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1400 QUAIL STREET SUITE 110 NEWPORT BEACH CA 92660
Business Address 1400 QUAIL STREET SUITE 110 NEWPORT BEACH CA 92660 949-872-2552
CureDuchenne Ventures, LLC (Reporting) CIK: 0001824590 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39509 | Film No.: 201179921